RNA Therapeutics Design Lead - siRNA & Computational Design

Grünenthal Group

Breukelen

Hybrid

EUR 110,000 - 160,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Grünenthal Group in the Netherlands is seeking a senior researcher to lead the design and computational optimisation of RNA therapeutics, including siRNA, blending RNA biology with oligonucleotide chemistry to drive gene knockdown and regulatory strategies.

You will define target sites, prioritise design approaches, and accelerate design–test–learn cycles using Python or R, collaborating with chemists and delivery scientists to maximise potency and tissue activity.

Qualifications

  • PhD in RNA biology, molecular biology, computational biology, bioinformatics, or a related discipline.
  • More than 10 years of relevant industry experience, including at least 5 years in therapeutic antisense or siRNA design and optimisation.
  • Strong computational skills, including experience developing scripts or workflows (e.g. Python or R).
  • Experience designing siRNA across CNS and systemic delivery contexts, including optimisation of sequence and chemistry for robust in vivo activity.
  • Proven track record contributing to or leading programs that progressed molecules to candidate stage, with demonstrated involvement in programs advancing toward clinical development.
  • Strong understanding of oligonucleotide optimisation and risk assessment across discovery and development stages.
  • Experience delivering siRNA therapeutics in liver and CNS indications is highly desirable, ideally including progression of molecules toward clinical development.

Responsibilities

  • Lead the design and computational optimisation of RNA therapeutics, particularly siRNA, integrating RNA biology with oligonucleotide chemistry to enable gene knockdown and RNA regulatory approaches.
  • Define and prioritise target sites and design strategies by integrating sequence features, RNA accessibility, transcript structure, cross-species alignment, and emerging experimental data.
  • Drive iterative design–test–learn cycles by analysing and rapidly integrating datasets linking sequence, chemistry, and biological activity to inform decision-making.
  • Develop and apply computational tools and workflows (e.g. Python or R) to enable scalable oligonucleotide design, data integration, and rapid sequence–chemistry iteration.
  • Partner closely with oligonucleotide chemists and delivery scientists to co-optimise sequence, chemical modifications, and delivery approaches to maximise potency, durability, and tissue activity.
  • Lead and contribute to discovery programs advancing RNA therapeutic candidates toward candidate profiling and clinical development, while helping prioritise and evaluate new targets aligned with platform capabilities.

Skills

RNA biology
Molecular biology
Computational biology
Bioinformatics
Python
R
siRNA design
Oligonucleotide design
Delivery strategies

Education

PhD in RNA biology, molecular biology, computational biology, bioinformatics, or a related discipline

Tools

Python
R

Job description

Grünenthal Group in the Netherlands is seeking a senior researcher to lead the design and computational optimisation of RNA therapeutics, including siRNA, blending RNA biology with oligonucleotide chemistry to drive gene knockdown and regulatory strategies.

You will define target sites, prioritise design approaches, and accelerate design–test–learn cycles using Python or R, collaborating with chemists and delivery scientists to maximise potency and tissue activity.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Oligonucleotide Design Lead (f/m/d)
Oligonucleotide Design Lead (f/m/d)

Grünenthal Group • Breukelen

Hybrid
EUR 110,000 - 160,000
RNA Therapeutics Study Physician | Medical Director
RNA Therapeutics Study Physician | Medical Director

ProQR Therapeutics N.V. • Netherlands

On-site
EUR 120,000 - 180,000
Annual performance bonus
Stock options
Pension plan
+3
Scientist – RNA Biology & Neuromuscular Gene Therapy (AAV)
Scientist – RNA Biology & Neuromuscular Gene Therapy (AAV)

CAREERS AT NLC • Nijmegen

On-site
EUR 50,000 - 55,000
Director, Toxicology — Translational RNA Therapeutics Leader
Director, Toxicology — Translational RNA Therapeutics Leader

ProQR Therapeutics N.V. • Netherlands

Remote
EUR 150,000 - 190,000
Annual bonus
Stock options
Pension plan
+3
RNA Biology Scientist - Neuromuscular Gene Therapy
RNA Biology Scientist - Neuromuscular Gene Therapy

NLC- The Healthtech Venture Builder • Nijmegen

On-site
EUR 50,000 - 55,000
On-site Nijmegen
Startup culture
Scientist | RNA Biology & Neuromuscular Gene Therapy
Scientist | RNA Biology & Neuromuscular Gene Therapy

NLC- The Healthtech Venture Builder • Nijmegen

On-site
EUR 50,000 - 55,000
On-site Nijmegen
Startup culture
Director, Nonclinical Toxicology — RNA Therapeutics
Director, Nonclinical Toxicology — RNA Therapeutics

ProQR Therapeutics NV • Leiden

On-site
EUR 180,000 - 260,000
8% holiday allowance
30 vacation days
Annual performance bonus
+6
Director Toxicology
Director Toxicology

ProQR Therapeutics N.V. • Netherlands

On-site
EUR 150,000 - 190,000
Annual bonus
Stock options
Pension plan
+3
Postdoctoral position Small Molecules that Repartition RNA Conformational Ensembles
Postdoctoral position Small Molecules that Repartition RNA Conformational Ensembles

Rijksuniversiteit Groningen • Groningen

On-site
EUR 47,000 - 49,000
Salary according to Dutch scales (4,25
232 vacation hours per year
End-year bonus
+2
CEO, RNA Therapeutics Startup: Lead Gene Therapy Breakthroughs
CEO, RNA Therapeutics Startup: Lead Gene Therapy Breakthroughs

NLC Health Ventures • Nijmegen

Hybrid
EUR 90,000 - 150,000
Equity-based compensation
Modest base salary until fundraising